News and Events

Today we remember and support #WorldAIDSDay. Medical research has seen amazing advances and milestones over the past few decades. Here at IRBM, we are proud to have played a major role in the discovery of Raltegravir (Isentress) while part of Merck & Co, for the treatment of #HIV-1 infection in combination with other antiretroviral agents.

According to the World Health Organization, there are 48 vaccine candidates in clinical trials and 164, still in the pre-clinical testing phase. Let’s analyze efficacy, safety and timing of the three the protagonists of this race.